
Laboratory Corporation of America Holdings LH
$ 317.34
1.18%
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSESPB |
Shares |
83.2 M |
Market Cap[1] |
$ 26.4 B |
EBITDA (LTM) |
$ 2.07 B |
P/E (LTM) |
31.014231 |
P/S (LTM) |
1.949386 |
EPS (LTM) |
10.54 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Biomerica
BMRA
|
$ 1.8 | 0.82 % | $ 5.25 M | Nasdaq Capital Market | ||
|
Myriad Genetics
MYGN
|
$ 4.15 | 1.72 % | $ 384 M | Nasdaq Global Select Market,SPB | ||
|
Pacific Biosciences of California
PACB
|
$ 1.99 | 0.73 % | $ 597 M | Nasdaq Global Select Market,SPB | ||
|
Neuronetics
STIM
|
$ 1.89 | 0.23 % | $ 125 M | Nasdaq Global Select Market | ||
|
Agilent Technologies
A
|
$ 174.0 | 1.39 % | $ 49.4 B | NYSE,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 302.0 | 1.0 % | $ 15 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | ||
|
Biodesix
BDSX
|
$ 23.99 | 0.18 % | $ 181 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.66 | 0.37 % | $ 86.3 K | Nasdaq Capital Market | ||
|
Precipio
PRPO
|
$ 22.25 | 1.0 % | $ 35.7 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 14.61 | 0.33 % | $ 154 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 13.5 | 0.22 % | $ 899 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 11.51 | 4.01 % | $ 391 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 64.69 | 0.31 % | $ 3.45 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 59.9 | 0.1 % | $ 2.8 B | Nasdaq Global Select Market | ||
|
Co-Diagnostics
CODX
|
$ 0.76 | 11.61 % | $ 1.01 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 33.11 | 0.7 % | $ 960 M | Nasdaq Global Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 224.69 | 0.83 % | $ 160 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 5.45 | 2.21 % | $ 21.7 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 83.47 | 0.6 % | $ 32.6 B | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 21.01 | 0.31 % | $ 647 M | Nasdaq Global Market | ||
|
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | ||
|
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Guardant Health
GH
|
$ 162.99 | 0.56 % | $ 20.4 B | Nasdaq Global Select Market,SPB | ||
|
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 262.01 | 0.51 % | $ 45 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 168.97 | 2.82 % | $ 13.3 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 271.76 | 0.22 % | $ 42.1 B | Nasdaq Global Select Market,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.37 | 0.74 % | $ 7.46 M | Nasdaq Capital Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 100.0 | 0.03 % | $ 6.75 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 616.63 | 1.11 % | $ 17.8 B | Nasdaq Global Select Market,SPB | ||
|
ENDRA Life Sciences
NDRA
|
$ 4.78 | 1.16 % | $ 3.76 M | Nasdaq Global Select Market | ||
|
NeoGenomics
NEO
|
$ 16.88 | 1.32 % | $ 2.16 B | Nasdaq Global Select Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 609.27 | 0.7 % | $ 33.2 B | NYSE,SPB | ||
|
National Research Corporation
NRC
|
$ 20.43 | 1.29 % | $ 457 M | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 12.13 | 3.41 % | $ 2.64 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.